The Fellows Grants support innovative research by a meritorious young investigator by presenting the Fellow with research funds to pursue an independent line of investigation within the context of his/her current Fellowship placement. These grants provide a "bridge" between a training and an independent position, offering an opportunity for young investigators to develop a new direction for his/her research program that otherwise may not have been possible in the absence of this funding.
Applications must be completed online using the proposalCENTRAL website, with one paper copy submitted to the AACR office. Application instructions and program guidelines are available below and on the proposalCENTRAL website.
AACR-Colorectal Cancer Coalition Fellows Grant, in memory of Lisa Dubow: One-year grant of $30,000. Research projects are restricted to translational or clinical cancer research that has an ultimate goal of developing or improving therapeutic interventions for patients with metastatic colorectal cancer. One grant will be awarded this cycle.
Application Deadline: November 18, 2009, at 12 noon, Eastern Time.
AACR-FNAB Fellows Grant for Translational Pancreatic Cancer Research: One-year grant of $35,000. Research projects are restricted to translational pancreatic cancer research that includes the use of human tissue and has implications for therapeutic application and individualized medicine. Proposed research must have implications for individualized cancer treatment and must make use of human biopsies or samples, such as needle biopsies or circulating cancer cells. In vivo primary tumor explants meet these criteria, but xenografts from established cell lines do not. One grant will be awarded this cycle.
Colorectal Cancer Coalition (C3) FNAB
Hanna Hopfinger, Grants Program Assistant Telephone: (267) 646-0665 Fax: (215) 440-9372 E-mail: grants@aacr.org
The AACR is proud to sponsor the AACR-Colorectal Cancer Coalition Fellows Grant, in memory of Lisa Dubow. Lisa Dubow, a founder of C3: Colorectal Cancer Coalition, was 42 years old when she was diagnosed with stage III colorectal cancer which later recurred. She credited cutting-edge research and clinical trials with helping her survive her diagnosis for nine years before her death on July 24, 2007. In 2006, Lisa worked with C3 to create the "Lisa Fund." The fund supports researchers who are dedicated to developing treatments for patients with late stage colorectal cancer. Through the Lisa Fund, C3 has partnered with the AACR to attract and reward researchers who are changing the future of colorectal cancer today.